Sitagliptin and metformin hydrochloride
NDC 70771-1870, Sitagliptin and Metformin Hydrochloride, tablet, film coated, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1870
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA216743
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1870 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SITAGLIPTIN50 mg/1
- METFORMIN HYDROCHLORIDE1000 mg/1
Pharmacologic classes
Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1870-6 | 70771187006 | 60 TABLET, FILM COATED in 1 BOTTLE (70771-1870-6) |
| 70771-1870-8 | 70771187008 | 180 TABLET, FILM COATED in 1 BOTTLE (70771-1870-8) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e07abcb1-1f0c-4cad-8405-8eedba4b8ff8
Use it
Look up 70771-1870 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1870 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1870. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.